Gene · 8000
Papers1,687
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,687
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments. | J Transl Med | 2023 | 37420216 | PubTator, text mining | PubMed |
| Fabrication of Antibody Conjugated Super Magnetic Oxide Nanoparticles for Early Detection of Prostate Cancer. | Asian Pac J Cancer Prev | 2023 | 37378940 | PubTator, text mining | PubMed |
| Bioengineered Bovine Papillomavirus L1 Protein Virus-like Particle (VLP) Vaccines for Enhanced Induction of CD8 T Cell Responses through Cross-Priming. | Int J Mol Sci | 2023 | 37372999 | PubTator, text mining | PubMed |
| Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer. | Cancers (Basel) | 2023 | 37370724 | PubTator, text mining | PubMed |
| Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer. | Ther Adv Urol | 2023 | 37359737 | PubTator, text mining | PubMed |
| Spatial and temporal diversity of positive selection on shared haplotypes at the PSCA locus among worldwide human populations. | Heredity (Edinb) | 2023 | 37353592 | PubTator, text mining | PubMed |
| T cells in health and disease. | Signal Transduct Target Ther | 2023 | 37332039 | PubTator, text mining | PubMed |
| Preclinical Characterization of the 177Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5. | Int J Mol Sci | 2023 | 37298374 | PubTator, text mining | PubMed |
| PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies. | Cancers (Basel) | 2023 | 37296886 | PubTator, text mining | PubMed |
| Advances in landscape and related therapeutic targets of the prostate tumor microenvironment. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37294106 | PubTator, text mining | PubMed |
| Therapeutic implications of cancer stem cells in prostate cancer. | Cancer Biol Med | 2023 | 37282627 | PubTator, text mining | PubMed |
| Characterisation of cell lines derived from prostate cancer patients with localised disease. | Prostate Cancer Prostatic Dis | 2023 | 37264224 | PubTator, text mining | PubMed |
| PSMA-Targeted Nanotheranostics for Imaging and Radiotherapy of Prostate Cancer. | Pharmaceuticals (Basel) | 2023 | 37259457 | PubTator, text mining | PubMed |
| In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer. | Nat Commun | 2023 | 37258521 | PubTator, text mining | PubMed |
| From bench to bedside: the history and progress of CAR T cell therapy. | Front Immunol | 2023 | 37256141 | PubTator, text mining | PubMed |
| A genome-wide CRISPR screen maps endogenous regulators of PPARG gene expression in bladder cancer. | iScience | 2023 | 37250326 | PubTator, text mining | PubMed |
| Advances, Limitations and Future Challenges in the Management of Immunotherapy for Hematological Diseases and Solid Tumors. | Int J Mol Sci | 2023 | 37240158 | PubTator, text mining | PubMed |
| The Interplay between T Cells and Cancer: The Basis of Immunotherapy. | Genes (Basel) | 2023 | 37239368 | PubTator, text mining | PubMed |
| Abnormal glycosylation in glioma: related changes in biology, biomarkers and targeted therapy. | Biomark Res | 2023 | 37231524 | PubTator, text mining | PubMed |
| New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer. | Mol Ther Oncolytics | 2023 | 37215386 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8000/papers?page=9